Generation Bio Co (NASDAQ: GBIO) on Monday, plunged -15.40% from the previous trading day, before settling in for the closing price of $0.36. Within the past 52 weeks, GBIO’s price has moved between $0.32 and $3.65.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -8.30%. The company achieved an average annual earnings per share of 45.62%. With a float of $45.82 million, this company’s outstanding shares have now reached $67.01 million.
Considering the fact that the conglomerate employs 115 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 100.0%, operating margin of -331.33%, and the pretax margin is -292.92%.
Generation Bio Co (GBIO) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Generation Bio Co is 31.65%, while institutional ownership is 54.54%. The most recent insider transaction that took place on Jan 10 ’25, was worth 120,759. In this transaction Director of this company bought 125,791 shares at a rate of $0.96, taking the stock ownership to the 214,286 shares. Before that another transaction happened on Jan 13 ’25, when Company’s Director bought 85,000 for $0.97, making the entire transaction worth $82,450. This insider now owns 299,286 shares in total.
Generation Bio Co (GBIO) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.26 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 45.62% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 24.37% during the next five years compared to -8.30% drop over the previous five years of trading.
Generation Bio Co (NASDAQ: GBIO) Trading Performance Indicators
Generation Bio Co (GBIO) is currently performing well based on its current performance indicators. A quick ratio of 8.43 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.82.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.08, a number that is poised to hit -0.28 in the next quarter and is forecasted to reach -1.07 in one year’s time.
Technical Analysis of Generation Bio Co (GBIO)
Compared to the last year’s volume of 0.58 million, its volume of 1.86 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 16.78%.
During the past 100 days, Generation Bio Co’s (GBIO) raw stochastic average was set at 0.00%, which indicates a significant increase from 0.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 101.10% in the past 14 days, which was higher than the 94.81% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3901, while its 200-day Moving Average is $1.0923. Nevertheless, the first resistance level for the watch stands at $0.3468 in the near term. At $0.3932, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.4164. If the price goes on to break the first support level at $0.2772, it is likely to go to the next support level at $0.2540. Now, if the price goes above the second support level, the third support stands at $0.2076.
Generation Bio Co (NASDAQ: GBIO) Key Stats
Market capitalization of the company is 20.14 million based on 67,035K outstanding shares. Right now, sales total 19,890 K and income totals -131,670 K. The company made 8,720 K in profit during its latest quarter, and -14,800 K in sales during its previous quarter.
